SAN DIEGO, CALIFORNIA (PRWEB) April 14, 2017
Local healthcare company, Sleep Data, moved into its new San Diego headquarters in Kearny Mesa at 5471 Kearny Villa Road on February 1st, 2017. Sleep Data moves into the new 16,000 square foot space that’s been specifically designed and constructed to cost effectively diagnose and treat people with obstructive sleep apnea. The company has grown from 30 employees in 2012 to over 100 in 2016 necessitating a move into a larger and more efficiently designed headquarters.
“Last year we expanded into two new satellite offices in Chula Vista and Escondido in addition to our already existing San Diego headquarters and Oceanside locations, to provide better and more accessible patient care,” stated Bretton Hevener, RPSGT and President of Sleep Data. “As more doctors and patients become aware of the importance of effectively treating obstructive sleep apnea, our business continues to grow and we’re able to hire more and more qualified people.”
The staff includes RPSGT’s (Registered Polysomnographic Technologist), Respiratory Therapists, as well as dedicated patient care coordinators and other support personnel.
The biggest keys to Sleep Data’s success are its unprecedented clinical experience and expertise at the executive leadership level, its proficiency in the area of patient compliance, and an unwavering focus on achieving the most desirable patient outcomes.
“We’ve assembled a management team here that has a passion for seeing the health benefits patients can achieve from appropriately administered sleep medicine,” stated Chief Medical Officer Dominic Munafo, M.D., DABSM. “When you combine that devotion to the field with the highest level of competence and decades of experience you’re able to create a special kind of care provider.”
In addition to Hevener and Dr. Munafo, Sleep Data leadership includes DME (Durable Medical Equipment) veteran CEO David French and growth strategist CTO Tay Nguyen.
Obstructive Sleep Apnea is a disease characterized by the collapse of the airway during sleep. Individuals diagnosed with OSA may experience both what are known as apneas and hypopneas while they sleep. An apnea is defined as the complete cessation of breathing, while a hypopnea is described as extremely shallow breathing, both of which can result in dangerous desaturation in patients’ oxygen levels. These apnea and hypopnea episodes may occur several times per minute, and are considered clinically significant when lasting for ten seconds or more.
Untreated sleep apnea leads to increased risk of heart failure, stroke, diabetes, hypertension, depression, and other co-morbid conditions. It’s estimated one in four American adults are affected by sleep apnea, yet more than 85% remain undiagnosed and untreated.
The gold standard for the treatment of OSA is CPAP (Continuous Positive Airway Pressure). With CPAP, a machine generates slightly pressurized air that is delivered to the airway through a tube and mask to keep the airway open during sleep. As a durable medical equipment provider, Sleep Data provides these machines to patients, but more importantly Respiratory Therapists and CPAP coaches work individually with patients throughout their treatment life cycle to encourage and support their successful compliance with the treatment. The industry standard for patient’s CPAP compliance is under 50% according to numerous IRB approved clinical studies. However, with the development of their patented patient data and population management software, Sleep Data achieves compliance rates of 83%. In comparison, compliance for patients taking hypertension pills is approximately 50%. Most experts in the field of sleep medicine consider sleep Data’s outcomes remarkable.
Additionally, Sleep Data offers OAT (Oral Appliance Therapy) as an OSA treatment option through Sleep Alliance, a partnership with Todd Morgan, DMD, ABDSM. For many patients, oral appliance therapy is more effective. Dr. Todd Morgan and Hevener together lead Sleep Alliance. Dr. Morgan is one of the most experienced and authoritative figures in the field of dental sleep medicine in the world. This partnership is another key part of the successful patient outcome and data driven model that Sleep Data has developed over time.
“When Bretton and I first began to discuss forming this partnership we talked about how my practice is founded in evidence based medicine, and scientifically proven treatment protocols,” Dr. Morgan stated. “It so happens that she and Dr. Munafo have the same approach so we knew it would be a great fit for us and for patients.”
For Sleep Data each patient’s life cycle often begins with a referral from their doctor for a sleep study. The patients schedule an initial appointment at one of Sleep Data’s four locations where home sleep studies are explained, demonstrated, and supplied to patients for completion overnight in the comfort of their own home. Once the study has been completed and analyzed by a board certified sleep physician, if a positive diagnosis is made, Sleep Data works with the treating physician to design and implement a treatment plan for each patient. The clinical and support staff continue to work with and advocate for each patient for the duration of their therapy. This model works to effectively and successfully treat patients with obstructive sleep apnea for the long-term. Sleep Data has plans to expand into new markets in the future.
Sleep Data was co-founded by home sleep testing pioneers Joanna Munafo and Jill Minch in Mission Valley in 1995.